Citations

Citations to this article as recorded by  

• Covid-19 in Parkinson's Disease treated by drugs or brain stimulation
  M. Salari, M. Etemadifar, A. Zali, Z. Aminzade, I. Navalpotro-Gomez, S. Tehrani Fateh
  Neurología.2024; 39(3): 254.     CrossRef
• Online dance classes during the Covid-19 pandemic: new challenges and teaching strategies for the ‘Dance & Parkinson’s at home’ project
  Marcela Dos Santos Delabary, Isadora Loch Sbeghen, Mariana Wolffenbuttel, Djefri Ramon Pereira, Aline Nogueira Haas
  Research in Dance Education.2024; 25(2): 118.     CrossRef
• Calidad de vida de las personas con enfermedad de Parkinson durante el confinamiento por la pandemia por covid-19
  A.M. Fernández-Elgueta, H.F. Retamal-Matus, C. Núñez-Espinosa, P. Barria Aburto
  Rehabilitación.2024; 58(1): 100821.     CrossRef
• Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson's disease: a multicenter randomized controlled trial
  Michela GOFFREDO, Francesca BAGLIO, Roberto DE ICCO, Stefania PROIETTI, Giorgio MAGGIONI, Andrea TUROLLA, Sanaz POURNAJAF, Johanna JONSDOTTIR, Federica ZENI, Sara FEDERICO, Luisa CACCIANTE, Matteo CIOETA, Cristina TASSORELLI, Marco FRANCESCHINI, Rocco S.
  European Journal of Physical and Rehabilitation Medicine.2024;[Epub]     CrossRef
• Covid-19 in Parkinson's Disease treated by drugs or brain stimulation
  M. Salari, M. Etemadifar, A. Zali, Z. Aminzade, I. Navalpotro-Gomez, S. Tehrani Fateh
  Neurología (English Edition).2024; 39(3): 254.     CrossRef
• COVID-19 and Parkinson’s disease: a systematic review and meta-analysis
  Maryam Afraie, Ghobad Moradi, Pardis Mohammadzedeh, Mobin Azami, Sevda Riyahifar, Yousef Moradi
  Acta Neurologica Belgica.2023; 123(4): 1209.     CrossRef
• Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease and Their Caregivers in Japan
  Nobutaka Hattori, Yoshiko Okada, Yayoi Kawata, Yoshihiko Furusawa, Takumi Imai, Hisako Yoshida, Mihoko Ota, Masaki Arai, Ayumi Shintani, Jovelle Fernandez
  Patient Preference and Adherence.2023; Volume 17: 1221.     CrossRef
• COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection
  Salvatore Iacono, Giuseppe Schirò, Chiara Davì, Sergio Mastrilli, Michelle Abbott, Fabrizio Guajana, Valentina Arnao, Paolo Aridon, Paolo Ragonese, Cesare Gagliardo, Claudia Colomba, Nicola Scichilone, Marco D’Amelio
  Frontiers in Neurology.2023;[Epub]     CrossRef
• Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy
  Christian Ineichen, Heide Vogel-Baumann, Matthias Sitzler, Günther Deuschl, Christian R. Baumann
  Journal of Parkinson's Disease.2023; 13(5): 845.     CrossRef
• The Impact of COVID-19 on Parkinson’s Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients’ Perceptions
  Gustav Cedergren Weber, Jonathan Timpka, Filip Bergquist, David Bäckström, Nil Dizdar, Karin Gunnarsson, Dag Nyholm, Per Svenningsson, Per Odin, Gessica Sala
  Acta Neurologica Scandinavica.2023; 2023: 1.     CrossRef
• Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
  Rodrigo León-García, Emmanuel Ortega-Robles, Oscar Arias-Carrión
  Brain Sciences.2023; 13(7): 1114.     CrossRef
• Social and economic development impact of elderly health care products based on design ethics
  Na Qi, Xun Zhang, Muhammad Attique Khan, Gaurav Dhiman, Sathishkumar VE
  Intelligent Data Analysis.2023; 27: 137.     CrossRef
• The effects of an individualized smartphone-based exercise program on self-defined motor tasks in Parkinson’s disease: a long-term feasibility study
  Lisa Lützow, Isabelle Teckenburg, Veronika Koch, Franz Marxreiter, Jelena Jukic, Sabine Stallforth, Martin Regensburger, Jürgen Winkler, Jochen Klucken, Heiko Gaßner
  Journal of Patient-Reported Outcomes.2023;[Epub]     CrossRef
• Doctor Hope; Calming and Comforting Loneliness in Parkinson’s Disease
  Sasivimol Virameteekul, Roongroj Bhidayasiri
  Clinical Parkinsonism & Related Disorders.2022; 6: 100131.     CrossRef
• Neurological toll of COVID-19
  Shivam Bhola, Jhillika Trisal, Vikram Thakur, Parneet Kaur, Saurabh Kulshrestha, Shashi Kant Bhatia, Pradeep Kumar
  Neurological Sciences.2022; 43(4): 2171.     CrossRef
• Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic
  Roberto Erro, Sofia Cuoco, Emanuele Nigro, Raffaele Ragone, Paolo Barone
  Journal of Movement Disorders.2022; 15(1): 77.     CrossRef
• Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer’s and Parkinson’s Disease
  Ankita Sood, Ravi Goyal, Harshdeep Singh, Tapan Behl, Sandeep Arora, Balraj Saini, Rajwinder Kaur
  CNS & Neurological Disorders - Drug Targets.2022; 21(3): 235.     CrossRef
• The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design
  Konrad Rejdak, Piotr Fiedor, Robert Bonek, Aleksander Goch, Agnieszka Gala-Błądzińska, Waldemar Chełstowski, Jacek Łukasiak, Sławomir Kiciak, Piotr Dąbrowski, Mateusz Dec, Zbigniew J. Król, Ewa Papuć, Adriana Zasybska, Agnieszka Segiet, Paweł Grieb
  Contemporary Clinical Trials.2022; 116: 106755.     CrossRef
• Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
  Jaime Silva, Felipe Patricio, Aleidy Patricio-Martínez, Gerardo Santos-López, Lilia Cedillo, Yousef Tizabi, Ilhuicamina Daniel Limón
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia
  Maria Antonietta Barbieri, Gianluca Bagnato, Carmelo Ioppolo, Antonio Giovanni Versace, Natasha Irrera
  CNS & Neurological Disorders - Drug Targets.2022; 21(10): 1017.     CrossRef
• Factors Related to Experiencing Pain in Patients Affected by Chronic Inflammatory Rheumatic Disease During the COVID-19 Pandemic
  Tfarah El Joumani, Hanan Rkain, Fatima Zahrae Taik, Kenza Hassouni, Redouane Abouqal, Sara Bahloul, Nada Alami, Latifa Tahiri, Najia Hajjaj-Hassouni, Fadoua Allali
  The Open Pain Journal.2022;[Epub]     CrossRef
• A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study
  Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova
  Neurology, Neuropsychiatry, Psychosomatics.2022; 14(6): 40.     CrossRef
• Attitudes toward telemedicine of patients with Parkinson’s disease during the COVID‐19 pandemic
  Kanako Kurihara, Koichi Nagaki, Kotoe Inoue, Sumiko Yamamoto, Takayasu Mishima, Shinsuke Fujioka, Shinji Ouma, Yoshio Tsuboi
  Neurology and Clinical Neuroscience.2021; 9(1): 77.     CrossRef
• Risk of Hospitalization and Death for COVID‐19 in People with Parkinson's Disease or Parkinsonism
  Luca Vignatelli, Corrado Zenesini, Laura M.B. Belotti, Elisa Baldin, Giuseppe Bonavina, Giovanna Calandra‐Buonaura, Pietro Cortelli, Carlo Descovich, Giovanni Fabbri, Giulia Giannini, Maria Guarino, Roberta Pantieri, Giuseppe Samoggia, Cesa Scaglione, Sus
  Movement Disorders.2021; 36(1): 1.     CrossRef
• Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
  Roberta Eduarda Grolli, Maiqueli Eduarda Dama Mingoti, Amanda Gollo Bertollo, Adriana Remião Luzardo, João Quevedo, Gislaine Zilli Réus, Zuleide Maria Ignácio
  Molecular Neurobiology.2021; 58(5): 1905.     CrossRef
• COVID-19: Implications for Sudden Death in Parkinson’s Disease
  Ana Claudia Fiorini, Marcelo Cunio Machado Fonseca, Carla Alessandra Scorza, Josef Finsterer, Antônio Márcio Rodrigues, Antônio-Carlos Guimarães de Almeida, Fulvio Alexandre Scorza
  Journal of Movement Disorders.2021; 14(1): 78.     CrossRef
• Impact and Challenges of the COVID-19 Pandemic on Patients Requiring Botulinum Toxin A Treatment
  Azalea Tenerife Pajo, Adrian Isidoro Espiritu, Roland Dominic Go Jamora
  Journal of Movement Disorders.2021; 14(1): 29.     CrossRef
• COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?
  Milena de Barros Viana, Bárbara dos Anjos Rosário, Maria de Fátima Santana de Nazaré, Débora Estadella, Daniel Araki Ribeiro, Glauce Socorro de Barros Viana
  Reviews in the Neurosciences.2021; 32(2): 235.     CrossRef
• How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review
  Agnes Langer, Lucia Gassner, Anna Flotz, Sebastian Hasenauer, Jakob Gruber, Laurenz Wizany, Rochus Pokan, Walter Maetzler, Heidemarie Zach
  npj Parkinson's Disease.2021;[Epub]     CrossRef
• Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
  Dipak Kumar, Sadaf Jahan, Andleeb Khan, Arif Jamal Siddiqui, Neeru Singh Redhu, Wahajuddin, Johra Khan, Saeed Banwas, Bader Alshehri, Mohammed Alaidarous
  Molecular Neurobiology.2021; 58(7): 3417.     CrossRef
• Auswirkungen der COVID-19 Pandemie auf die medizinische Versorgung von Patienten mit angeborenen Blutungsneigungen
  Martin Olivieri, Susan Halimeh, Cornelia Wermes, Wolf Hassenpflug, Katharina Holstein, Sylvia von Mackensen
  Das Gesundheitswesen.2021; 83(04): 282.     CrossRef
• Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns
  Onanong Phokaewvarangkul, Sasivimol Virameteekul, Roongroj Bhidayasiri
  Parkinsonism & Related Disorders.2021; 87: 39.     CrossRef
• Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
  Raphael Scherbaum, Eun Hae Kwon, Daniel Richter, Dirk Bartig, Ralf Gold, Christos Krogias, Lars Tönges
  Movement Disorders.2021; 36(5): 1049.     CrossRef
• Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain & COVID-19 pan-Canadian study
  Lise Dassieu, M. Gabrielle Pagé, Anaïs Lacasse, Maude Laflamme, Vickie Perron, Audrée Janelle-Montcalm, Maria Hudspith, Gregg Moor, Kathryn Sutton, James M Thompson, Manon Choinière
  International Journal for Equity in Health.2021;[Epub]     CrossRef
• The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson’s Disease: An Updated Systematic Review
  Vikash Jaiswal, Danah Alquraish, Zouina Sarfraz, Azza Sarfraz, Shavy Nagpal, Prakriti Singh Shrestha, Dattatreya Mukherjee, Prathima Guntipalli, Diana F. Sánchez Velazco, Arushee Bhatnagar, Saloni Savani, Elmjedina Halilaj, Samir Ruxmohan, Wilson Cueva
  Journal of Primary Care & Community Health.2021; 12: 215013272110397.     CrossRef
• Personalized Medicine in Parkinson’s Disease: New Options for Advanced Treatments
  Takayasu Mishima, Shinsuke Fujioka, Takashi Morishita, Tooru Inoue, Yoshio Tsuboi
  Journal of Personalized Medicine.2021; 11(7): 650.     CrossRef
• Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
  Mehri Salari, Masoud Etemadifar, Farzad Ashrafi, Davood Ommi, Zahra Aminzade, Sepand Tehrani Fateh
  Parkinsonism & Related Disorders.2021; 89: 90.     CrossRef
• COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management
  Galit Yogev-Seligmann, Michal Kafri
  BMC Neurology.2021;[Epub]     CrossRef
• Management of Parkinson’s Disease in the COVID-19 Pandemic and Future Perspectives in the Era of Vaccination
  Yue Hui Lau, Keng Ming Lau, Norlinah Mohamed Ibrahim
  Journal of Movement Disorders.2021; 14(3): 177.     CrossRef
• Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
  Smriti Sinha, Swati Mittal, Rupali Roy
  Journal of Movement Disorders.2021; 14(3): 184.     CrossRef
• Impact of COVID‐19 on Patient Care, Training, and Research in Movement Disorders in MDS‐AOS Region
  Shweta Prasad, Hrishikesh Kumar, Roongroj Bhidayasiri, Pramod Kumar Pal
  Movement Disorders.2021; 36(11): 2457.     CrossRef
• Secondary Impact of COVID-19 Pandemic on People with Parkinson’s Disease—Results of a Polish Online Survey
  Karolina Krzysztoń, Beata Mielańczuk-Lubecka, Jakub Stolarski, Anna Poznańska, Katarzyna Kępczyńska, Agata Zdrowowicz, Izabela Domitrz, Jan Kochanowski
  Brain Sciences.2021; 12(1): 26.     CrossRef
• Dance as Lifeline: Transforming Means for Engagement and Connection in Times of Social Isolation
  Maria Portman Kelly, David Leventhal
  Health Promotion Practice.2021; 22(1_suppl): 64S.     CrossRef
• Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital
  Adalberto STUDART-NETO, Bruno Fukelmann GUEDES, Raphael de Luca e TUMA, Antonio Edvan CAMELO FILHO, Gabriel Taricani KUBOTA, Bruno Diógenes IEPSEN, Gabriela Pantaleão MOREIRA, Júlia Chartouni RODRIGUES, Maíra Medeiros Honorato FERRARI, Rafael Bernhart CAR
  Arquivos de Neuro-Psiquiatria.2020; 78(8): 494.     CrossRef
• Potential impact and challenges associated with Parkinson’s disease patient care amidst the COVID-19 global pandemic
  Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, Cindy Wen
  Journal of Clinical Movement Disorders.2020;[Epub]     CrossRef
• COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
  David Sulzer, Angelo Antonini, Valentina Leta, Anna Nordvig, Richard J. Smeyne, James E. Goldman, Osama Al-Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco, Olimpia Meucci, Elena Moro, Ashley S. Harms, Yaqian Xu, Stanley Fahn, K. Ray Chaudhuri
  npj Parkinson's Disease.2020;[Epub]     CrossRef
• Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease
  Shweta Prasad, VikramVenkappayya Holla, Koti Neeraja, BharathKumar Surisetti, Nitish Kamble, Ravi Yadav, PramodKumar Pal
  Neurology India.2020; 68(4): 792.     CrossRef
• The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
  Ethan G. Brown, Lana M. Chahine, Samuel M. Goldman, Monica Korell, Emerald Mann, Daniel R. Kinel, Vanessa Arnedo, Kenneth L. Marek, Caroline M. Tanner
  Journal of Parkinson's Disease.2020; 10(4): 1365.     CrossRef
• Impact of COVID‐19 pandemic on mental health of patients with inherited bleeding disorders in Germany
  Sylvia von Mackensen, Susan Halimeh, Manuela Siebert, Cornelia Wermes, Wolf Hassenpflug, Katharina Holstein, Martin Olivieri
  Haemophilia.2020;[Epub]     CrossRef
• Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish Patients
  Diego Santos‐García, Mila Oreiro, Patricia Pérez, Gemma Fanjul, Jose Manuel Paz González, María José Feal Painceiras, Carlos Cores Bartolomé, Lorena Valdés Aymerich, Carlos García Sancho, Maria del Mar Castellanos Rodrigo
  Movement Disorders.2020; 35(10): 1712.     CrossRef
• The Impact of COVID‐19 on Access to Parkinson's Disease Medication
  Julia Ling‐Yu Cheong, Zhao Hang Keith Goh, Connie Marras, Caroline M. Tanner, Meike Kasten, Alastair J. Noyce
  Movement Disorders.2020; 35(12): 2129.     CrossRef
• Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis
  Vikram Venkappayya Holla, Koti Neeraja, Bharath Kumar Surisetti, Shweta Prasad, Nitish Kamble, Dwarakanath Srinivas, Ravi Yadav, Pramod Kumar Pal
  Journal of Movement Disorders.2020; 13(3): 218.     CrossRef
• Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center
  Joy Antonelle de Marcaida, Jeffrey Lahrmann, Duarte Machado, Lawrence Bluth, Michelle Dagostine, Maria Moro-de Casillas, Elena Bortan, Sulada Kanchana, Mark Alberts
  Geriatrics.2020; 5(3): 54.     CrossRef
• Update on Neurological Manifestations of SARS-CoV-2
  Hisham Valiuddin, Almir Kalajdzic, James Rosati, Kevin Boehm, Dominique Hill
  Western Journal of Emergency Medicine.2020;[Epub]     CrossRef
• Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey
  Carla Piano, Francesco Bove, Tommaso Tufo, Isabella Imbimbo, Danilo Genovese, Alessandro Stefani, Massimo Marano, Antonella Peppe, Livia Brusa, Rocco Cerroni, Francesco Motolese, Enrico Di Stasio, Marianna Mazza, Antonio Daniele, Alessandro Olivi, Paolo C
  Frontiers in Neurology.2020;[Epub]     CrossRef